Author details

Full Name

Andrew K Lee

Affiliation

Texas Center for Proton Therapy

ORCID

Career Start Year

2001

Papers

126

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37597805	Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer center.	Radiother Oncol	2023
36412611	Exploring Psychosocial Dynamics Underpinning Driver Identity in an Older Adult Sample.	Geriatrics (Basel)	2022
34285935	Beam-Specific Spot Guidance and Optimization for PBS Proton Treatment of Bilateral Head and Neck Cancers.	Int J Part Ther	2021
29759487	Clinical examination of proton pencil beam scanning on a moving anthropomorphic lung phantom.	Med Dosim	2019
27635624	Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial.	Am J Clin Oncol	2018
30106637	Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer.	J Clin Oncol	2018
30402360	Four-dimensional Plan Optimization for the Treatment of Lung Tumors Using Pencil-beam Scanning Proton Radiotherapy.	Cureus	2018
27548839	Qigong/tai chi for sleep and fatigue in prostate cancer patients undergoing radiotherapy: a randomized controlled trial.	Psychooncology	2017
29114589	Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial.	Adv Radiat Oncol	2017
24732810	The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer.	Am J Clin Oncol	2016
31772973	Proton Beam Therapy for Localized Prostate Cancer: Results from a Prospective Quality-of-Life Trial.	Int J Part Ther	2016
27370116	Quantitative analysis of treatment process time and throughput capacity for spot scanning proton therapy.	Med Phys	2016
26059275	Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance.	BJU Int	2016
25714186	Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance.	BJU Int	2016
25413401	Proton therapy for seminoma: Case report describing the technique, efficacy, and advantages of proton-based therapy for seminoma.	Pract Radiat Oncol	2015
26080435	PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.	Proc Natl Acad Sci U S A	2015
25867000	Towards effective and efficient patient-specific quality assurance for spot scanning proton therapy.	Cancers (Basel)	2015
25988689	Proton therapy for prostate cancer: why and what orthopaedic surgeons need to know about it.	J Surg Orthop Adv	2015
24050892	Declining use of brachytherapy for the treatment of prostate cancer.	Brachytherapy	2014
25415688	Proton beam therapy for the treatment of prostate cancer.	Cancer J	2014
25212571	A single-field integrated boost treatment planning technique for spot scanning proton therapy.	Radiat Oncol	2014
24994920	Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic.	J Natl Compr Canc Netw	2014
24889208	Telemedicine and telesurgery in cancer care: inaugural conference at MD Anderson Cancer Center.	J Surg Oncol	2014
24931803	Current clinical presentation and treatment of localized prostate cancer in the United States.	J Urol	2014
24661661	Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial.	Int J Radiat Oncol Biol Phys	2014
24434775	Real-time in vivo rectal wall dosimetry using plastic scintillation detectors for patients with prostate cancer.	Phys Med Biol	2014
22673704	Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy.	Brachytherapy	2013
24674406	Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer.	Pract Radiat Oncol	2013
24674325	Proton beam therapy for the treatment of prostate cancer.	Pract Radiat Oncol	2013
24139077	Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.	Int J Radiat Oncol Biol Phys	2013
23939133	Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients.	Prostate Cancer Prostatic Dis	2013
23688812	Statistical assessment of proton treatment plans under setup and range uncertainties.	Int J Radiat Oncol Biol Phys	2013
23747223	Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errors.	Med Dosim	2013
23798338	Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation.	Cancer	2013
23726001	A fully automated method for CT-on-rails-guided online adaptive planning for prostate cancer intensity modulated radiation therapy.	Int J Radiat Oncol Biol Phys	2013
23387726	Use of treatment log files in spot scanning proton therapy as part of patient-specific quality assurance.	Med Phys	2013
23540491	Dosimetric effects of weight loss or gain during volumetric modulated arc therapy and intensity-modulated radiation therapy for prostate cancer.	Med Dosim	2013
23102837	PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era.	Int J Radiat Oncol Biol Phys	2013
22836052	Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?	Int J Radiat Oncol Biol Phys	2013
21703781	A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties.	Int J Radiat Oncol Biol Phys	2012
24674130	Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy.	Pract Radiat Oncol	2012
23180976	In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors.	Radiat Meas	2012
22955660	Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy.	J Appl Clin Med Phys	2012
23051714	Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer.	Phys Med Biol	2012
22704703	A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment.	Int J Radiat Oncol Biol Phys	2012
22727472	Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostate.	Brachytherapy	2012
22894449	Uncertainty incorporated beam angle optimization for IMPT treatment planning.	Med Phys	2012
22465551	Endoscopically assisted decompression for pronator syndrome.	J Hand Surg Am	2012
22290249	Improvement in prostate cancer survival over time: a 20-year analysis.	Cancer J	2012
22336663	Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?	Eur J Cancer	2012

1 - 50 of 126

Rachel M Glicksman

University of Toronto, Princess Margaret Cancer Centre, University Health Network

Career Start Year 2013

Number of shared co-authors 0

Alan Dal Pra

University of Miami Miller School of Medicine

Career Start Year 2010

Number of shared co-authors 2

Amar U Kishan

University of California los angeles

Career Start Year 2008

Number of shared co-authors 6

Suneil Jain

Cancer Centre Belfast City Hospital, Queen's University Belfast

Career Start Year 2008

Number of shared co-authors 0

Bridget F Koontz

Duke University School of Medicine

Career Start Year 2006

Number of shared co-authors 5

Alejandro Berlin

University of Toronto, Princess Margaret Cancer Centre

Career Start Year 2004

Number of shared co-authors 4

Albert J Chang

University of California Los Angeles

Career Start Year 2003

Number of shared co-authors 2

Mark K Buyyounouski

Stanford University

Career Start Year 1999

Number of shared co-authors 4

Danny Y Song

Johns Hopkins University School of Medicine

Career Start Year 1999

Number of shared co-authors 2

Daniel J Krauss

William Beaumont School of Medicine

Career Start Year 1999

Number of shared co-authors 3

Robert B Den

Thomas Jefferson University Hospital

Career Start Year 1999

Number of shared co-authors 4

Brian J Davis

Mayo Clinic

Career Start Year 1997

Number of shared co-authors 3

Constantine A Mantz

University of Chicago

Career Start Year 1997

Number of shared co-authors 4

Eric Vigneault

Centre Hospitalier Universitaire de Quebec

Career Start Year 1997

Number of shared co-authors 1

Gert De Meerleer

University Hospitals Leuven

Career Start Year 1997

Number of shared co-authors 2

Vincent Khoo

The Royal Marsden NHS Foundation Trust and Institute of Cancer Research

Career Start Year 1996

Number of shared co-authors 2

Eric M Horwitz

Fox Chase Cancer Center

Career Start Year 1996

Number of shared co-authors 4

Andrew Loblaw

Princess Margaret Hospital, University of Toronto

Career Start Year 1995

Number of shared co-authors 1

Jay P Ciezki

Cleveland Clinic

Career Start Year 1995

Number of shared co-authors 3

Jonathan D Tward

Huntsman Cancer Institute, University of Utah

Career Start Year 1994

Number of shared co-authors 3

William Robert Lee

Duke University School of Medicine

Career Start Year 1993

Number of shared co-authors 5

Patrick A Kupelian

university of california los angeles Medical Center

Career Start Year 1993

Number of shared co-authors 4

Thomas M Pisansky

Mayo Clinic

Career Start Year 1992

Number of shared co-authors 4

Theodore L DeWeese

Johns Hopkins University School of Medicine

Career Start Year 1991

Number of shared co-authors 4

Richard Choo

Mayo Clinic

Career Start Year 1991

Number of shared co-authors 1

Christopher R King

University of California los angeles

Career Start Year 1988

Number of shared co-authors 3

Seth A Rosenthal

Sutter Cancer Centers Radiation Oncology Services

Career Start Year 1987

Number of shared co-authors 4

Donald B Fuller

Division of Genesis Healthcare Partners Inc., CyberKnife Centers of San Diego Inc.

Career Start Year 1986

Number of shared co-authors 0

Mack Roach

University of California San Francisco

Career Start Year 1983

Number of shared co-authors 6

Howard M Sandler

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center

Career Start Year 1976

Number of shared co-authors 4

row(s) 1 - 30 of 30

Radhe Mohan

The University of Texas MD Anderson Cancer Center

Co-authored papers 13

Lifei Zhang

The University of Texas MD Anderson Cancer Center.

Co-authored papers 8

Anthony V D'Amico

Duke University Medical Center

Co-authored papers 6

Alan Pollack

University of Miami Miller School of Medicine

Co-authored papers 5

Philippe E Spiess

H. Lee Moffitt Cancer Center and Research Institute

Co-authored papers 4

Paul L Nguyen

Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School

Co-authored papers 4

Laurence E Court

The University of Texas MD Anderson Cancer Center

Co-authored papers 3

Surena F Matin

The University of Texas MD Anderson Cancer Center

Co-authored papers 2

Ming-Hui Chen

Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School

Co-authored papers 2

Abenaa M Brewster

The University of Texas MD Anderson Cancer Center

Co-authored papers 1

Dirce Maria Carraro

AC Camargo Cancer Center

Co-authored papers 1

Kevin Camphausen

National Cancer Institute

Co-authored papers 1

Emmanuel Dias-Neto

A.C. Camargo Cancer Center

Co-authored papers 1

Puneeth Iyengar

UT Southwestern Medical Center, Center for Human Nutrition

Co-authored papers 1

Jeff M Michalski

Washington University School of Medicine

Co-authored papers 1

Richard L Sidman

Harvard Medical School

Co-authored papers 1

Angela Simmons

Madigan Army Medical Center

Co-authored papers 1

Wenhua Cao

The University of Texas MD Anderson Cancer Center

Co-authored papers 1

Nora M Navone

MD Anderson Cancer Center

Co-authored papers 1

Sharon H Giordano

The University of Texas MD Anderson Cancer Center

Co-authored papers 1

Laurel Hyle

Baylor College of Medicine, Texas Children's Hospital

Co-authored papers 1

Yu Shen

Co-authored papers 1

Eleni Efstathiou

Houston Methodist Cancer Center

Co-authored papers 1

Diana N Nunes

A.C. Camargo Cancer Center

Co-authored papers 1

Oliver B??gler

American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University

Co-authored papers 1

Webster K Cavenee

Ludwig Institute for Cancer Research, University of California San Diego

Co-authored papers 1

Rebecca M Howell

The University of Texas M. D. Anderson Cancer Center

Co-authored papers 1

Robert L Satcher

The University of Texas MD Anderson Cancer Center

Co-authored papers 1

Robert W Williams

Mayo Clinic